home / stock / agrx / agrx news


AGRX News and Press, Agile Therapeutics Inc. From 12/04/23

Stock Information

Company Name: Agile Therapeutics Inc.
Stock Symbol: AGRX
Market: OTC
Website: agiletherapeutics.com

Menu

AGRX AGRX Quote AGRX Short AGRX News AGRX Articles AGRX Message Board
Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

AGRX - Top Penny Stocks To Buy Now? 4 To Watch Under $4

2023-12-04 13:30:59 ET Whether you subscribe to the idea that penny stocks are always a buy or determine your strategy based on broader market conditions, chances are that cheap stocks are on your watch list. While these sweeping market trends might not influence low-priced equities...

AGRX - Agile Therapeutics reports Q3 results

2023-11-22 09:26:16 ET More on Agile Therapeutics Agile Therapeutics, Inc. (AGRX) Q3 2023 Earnings Call Transcript Agile Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation Agile Therapeutics Q3 2023 Earnings Preview Seeking Alpha’s Quant...

AGRX - Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024

PRINCETON, NJ / ACCESSWIRE / November 22, 2023 / Agile Therapeutics, Inc. (NASDAQ:AGRX), the commercial-stage women's healthcare company, posted a 122% increase in third-quarter revenue year-over-year, driven by strong demand for TwirlaⓇ (levonorgestrel and ethinyl estradiol) transdermal ...

AGRX - Agile Therapeutics, Inc. (AGRX) Q3 2023 Earnings Call Transcript

2023-11-09 13:14:03 ET Agile Therapeutics, Inc. (AGRX) Q3 2023 Earnings Call November 9, 2023 08:30 AM ET Company Participants Matt Riley - Head of Investor Relations Alfred Altomari - Chairman and Chief Executive Officer Scott Coiante - Chief Financial Officer ...

AGRX - Agile Therapeutics Non-GAAP EPS of -$1.47 beats by $0.37, revenue of $6.66M beats by $0.31M

2023-11-09 08:12:42 ET More on Agile Therapeutics Agile Therapeutics Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Agile Therapeutics Historical earnings data for Agile Therapeutics Financial information for Agile Therapeutics For fu...

AGRX - Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Twirla Delivers Third Quarter 2023 Net Revenue of $6.7 Million, a 21% Increase from Second Quarter 2023 Company Announces It Expects to Generate Positive Cash Flow from Operations in First Quarter 2024 Gross Margin Grows to 63% in Third Quarter 2023 from 58% in Second Quarter 20...

AGRX - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

AGRX - Expected earnings - Agile Therapeutics Inc.

Agile Therapeutics Inc. (AGRX) is expected to report for Q3 2023

AGRX - Agile Therapeutics Q3 2023 Earnings Preview

2023-11-08 12:18:29 ET More on Agile Therapeutics Seeking Alpha’s Quant Rating on Agile Therapeutics Historical earnings data for Agile Therapeutics Financial information for Agile Therapeutics For further details see: Agile Therapeutics Q3 2023 Ea...

AGRX - Notable earnings before Thursday's open

2023-11-08 10:38:30 ET Major earnings expected before the bell on Thursday include: AstraZeneca ( AZN ) Fiverr International ( FVRR ) Li Auto ( LI ) Novavax ( NVAX ) Petróleo Brasileiro S.A. ( PBR ) For further details see: Nota...

Previous 10 Next 10